PRELUDE CAPITAL MANAGEMENT, LLC - ATHIRA PHARMA INC ownership

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$64,482
-23.9%
31,922
+11.1%
0.00%
-33.3%
Q2 2023$84,730
-21.1%
28,722
-33.1%
0.01%0.0%
Q1 2023$107,393
-46.0%
42,957
-31.5%
0.01%
-40.0%
Q4 2022$198,829
+9.2%
62,722
+2.5%
0.01%
+42.9%
Q3 2022$182,000
+87.6%
61,222
+92.5%
0.01%
+133.3%
Q2 2022$97,000
-34.9%
31,800
+189.1%
0.00%
-25.0%
Q1 2022$149,000
+52.0%
11,000
+5.8%
0.00%
+33.3%
Q3 2021$98,00010,4000.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Logos Global Management LP 1,630,744$21,249,0002.19%
VR Adviser, LLC 1,000,000$13,030,0001.78%
ACUTA CAPITAL PARTNERS, LLC 310,030$4,040,0001.70%
Ikarian Capital, LLC 860,000$11,207,0001.67%
Bristlecone Advisors, LLC 761,563$9,923,0001.19%
Perceptive Advisors 6,851,832$89,280,0000.69%
DAFNA Capital Management LLC 160,983$2,098,0000.53%
PATHSTONE FAMILY OFFICE, LLC 1,442,247$18,792,0000.47%
Potomac Capital Management, Inc. 40,000$521,0000.46%
RTW INVESTMENTS, LP 1,906,557$24,842,0000.36%
View complete list of ATHIRA PHARMA INC shareholders